Sunday August 20th 2017

Archive for November, 2013

Exploring the human tear fluid: discovery of new biomarkers in multiple sclerosis

Exploring the human tear fluid: discovery of new biomarkers in multiple sclerosis

Conclusions and clinical relevanceThis study supports the concept that modifications of the tear proteome can reflect biological abnormalities associated with multiple sclerosis and perhaps other inflammatory conditions affecting the CNS. In addition, [Read More]

GW Pharmaceuticals obtains Swiss approval for Sativex

GW Pharmaceuticals obtains Swiss approval for Sativex

GW Pharmaceuticals has received full marketing authorisation from the Swiss authorities for its prescription medicine Sativex to treat moderate to severe spasticity in multiple sclerosis (MS) patients who have not responded to other medications. (Source: Pharmaceutical [Read More]

Marijuana treatments for autoimmune disorders

Marijuana treatments for autoimmune disorders

Researchers from the University of South Carolina say that tetrahydrocannabinol, the principal constituent of marijuana, may have another medical use - treating those with autoimmune disorders.Tetrahydrocannabinol (THC) is known to have analgesic effects so can be used to [Read More]

 Page 1 of 69  1  2  3  4  5 » ...  Last »